Company: INKT
Filing Date: 2025-09-29
Form Type: 8-K
Source: 0001193125-25-221863
Chunk: 1

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-09-29
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1Press Release dated September 29, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      September 29, 2025      By:      /s/ Jennifer S. Buell, Ph. D.   
 ──────────────────────────────────────────────────────────────────────────────
                                              Jennifer S. Buell, Ph. D., CEO